Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
نویسندگان
چکیده
منابع مشابه
Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
UNLABELLED Aims/Introduction: Although the improvement of postprandial hyperglycemia by an alpha-glucosidase inhibitor (α-GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefore examined whether ameliorating the postprandial state by α-GI leads to an improvement...
متن کاملAssociation of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus
OBJECTIVE Type 2 diabetes mellitus (T2DM) is associated with subclinical myocardial injury although the underlying mechanism is uncertain. We postulated that arterial stiffness, endothelial dysfunction and subclinical atherosclerosis may contribute to subclinical myocardial injury in patients with T2DM. METHODS Serum high-sensitivity troponin I (hs-TNI) an indicator of myocardial injury, was ...
متن کاملEffect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.
OBJECTIVE To evaluate the effect of dipeptidyl-peptidase-4 (DPP-4) inhibitor vildagliptin on high sensitivity C-reactive protein (hsCRP) and arterial stiffness (AS) in patients with type 2 diabetes (T2DM). DESIGN Sixty-four drug-naive diabetic patients, with inadequate glycemic control, participated in this randomized, open-label study. Half of the patients received metformin 1700 mg/d and th...
متن کاملAssociation of cardiac autonomic neuropathy with arterial stiffness in type 2 diabetes mellitus patients
BACKGROUND Diabetic patients are at the risk of cardiac autonomic neuropathy (CAN) and arterial stiffness. This study aimed to investigate the association of heart rate variability (HRV) as an index for CAN and pulse wave velocity (PWV) as an index for arterial stiffness. METHODS Uncomplicated diabetes type-2 patients who had no apparent history of cardiovascular condition underwent HRV and P...
متن کاملBrief Report Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus
Background. Arterial stiffness assessed by pulse wave velocity (PWV) predicts all-cause and cardiovascular mortality in diabetic patients with end-stage renal disease. We studied the preventive effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on arterial PWV values in this population. Methods. Twenty-two patients with normal serum lipid levels received fluvas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Diabetes Investigation
سال: 2010
ISSN: 2040-1116
DOI: 10.1111/j.2040-1124.2010.00079.x